ON MOTION

ORDER

Paddock Laboratories, Inc. moves for summary affirmance of the United States District Court for the District of Minnesota’s judgment on the pleadings in favor of Paddock on Novo Nordisk, Inc. and Novo Nordisk A/S’s (collectively “Novo”) patent infringement claim. Novo opposes, and moves to “coordinate” this appeal with Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd., Appeal No.2011-1223. 1 Novo also moves to stay the present appeal pending the Supreme Court’s decision in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S, No. 10-844. 2 Paddock opposes these motions by Novo, and further presents a “cross-motion” in the alternative to lift this court’s stay of Appeal No.2011-1223 pend *962 ing the Supreme Court’s disposition of Caraco. 3

We deem it the better course to stay the present appeal pending the Supreme Court’s disposition of Caraco.

Upon consideration thereof,

It Is Ordered That:

(1) Paddock’s motion for summary affir-mance is denied without prejudice.

(2) Novo’s motion is granted to the extent that this appeal is stayed pending the disposition of Caraco. The parties are directed to inform this court, within 14 days of the Supreme Court’s disposition of Caraco, concerning how they believe this appeal should proceed.

(3) Paddock’s cross-motion to lift this court’s stay of the Appeal No.2011-1223 is denied.